找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hodgkin Lymphoma; A Comprehensive Over Andreas Engert,Anas Younes Book 20152nd edition Springer International Publishing 2015 CD30.Combined

[復(fù)制鏈接]
樓主: controllers
21#
發(fā)表于 2025-3-25 06:37:15 | 只看該作者
Andreas Engert,Anas YounesEvaluates new treatment options for both first-line and relapsed disease.Offers clear guidance on management of special patient groups and Hodgkin survivors.Discusses pathogenesis, clinical evaluation
22#
發(fā)表于 2025-3-25 09:40:43 | 只看該作者
Hematologic Malignancieshttp://image.papertrans.cn/h/image/427831.jpg
23#
發(fā)表于 2025-3-25 12:45:18 | 只看該作者
Prognostic Factors studies of patients treated with different treatment modalities. Survival curves according to Ann Arbor stage for more than 8,000 patients from the United States National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) programme are shown in Fig. 8.1.
24#
發(fā)表于 2025-3-25 16:35:06 | 只看該作者
Principles of Radiation Therapy for Hodgkin Lymphomamotherapy. As the role of RT has transformed over the years from a single modality into a component of combined-modality therapy, the classic principles of RT fields, dose, and technique have fundamentally changed.
25#
發(fā)表于 2025-3-25 23:57:52 | 只看該作者
26#
發(fā)表于 2025-3-26 00:38:25 | 只看該作者
Principles of Chemotherapy in Hodgkin Lymphomaion. Patients with advanced disease represent a minority of those affected by Hodgkin lymphoma. However, these patients represent the group in which the development and effects of chemotherapy are most readily appreciated, since the role of radiation therapy is markedly less than in those with localized disease.
27#
發(fā)表于 2025-3-26 06:51:39 | 只看該作者
The Management of Older Patients with Hodgkin Lymphomaar benefit for older patients, especially for advanced-stage disease. Survival rates for HL patients aged ≥60 years are significantly and disproportionately inferior compared with younger patient populations.
28#
發(fā)表于 2025-3-26 09:38:54 | 只看該作者
Functional Imaging in Hodgkin Lymphomaa) a high chemo- and radiosensitivity of the tumour, (b) an increasing accuracy of staging procedures, and (c) different treatment strategies tailored to well-defined categories of patients with a different risk of treatment failure.
29#
發(fā)表于 2025-3-26 14:48:26 | 只看該作者
30#
發(fā)表于 2025-3-26 17:40:40 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-6 14:23
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
宜宾县| 札达县| 鄂伦春自治旗| 金坛市| 临海市| 萨迦县| 资阳市| 翁牛特旗| 建宁县| 景洪市| 墨脱县| 苏尼特右旗| 商水县| 邹城市| 绩溪县| 蒙自县| 竹溪县| 朝阳县| 南岸区| 绥滨县| 绥江县| 静海县| 分宜县| 马山县| 图木舒克市| 瑞丽市| 梅河口市| 富源县| 宜兴市| 彭泽县| 星子县| 南康市| 获嘉县| 措美县| 黎平县| 南投县| 祁门县| 织金县| 墨江| 高台县| 商南县|